TIME—tumour immune microenvironment; ER—estrogen receptor; HER2—Human Epidermal Growth Factor Receptor 2; TILs—tumour-infiltrating lymphocytes; PD-1/PD-L1—Program Death Receptor/Ligand; TILB—tumour-infiltrating lymphocytes B; N—cohort size and number of reference in brackets. Here, ESR1 is linked to neoplasm.